Jefferies puts Kendle at buy

Kendle International Inc. was reiterated at a buy rating by Jefferies & Co., Inc. analyst David Windley. Jefferies raised its price target to $32.50 from $28.00. Management provided 2006 guidance that "easily surpassed" the analyst's estimates. While the company's fourth-quarter 2005 GAAP earnings per share of $0.25 beat Jefferies' estimate of $0.24, sales of $52.8 million missed the analyst's estimate of $54 million. Consensus estimates were $0.26 and $54.2 million. Shares of the Cincinnati pharmaceutical company were down 15 cents, or 0.51%, at $28.99 on volume of 293,752 shares versus the three-month running average of 111,908 shares. (Nasdaq: KNDL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.